/
The challenges of early diagnosis of cancer in primary care The challenges of early diagnosis of cancer in primary care

The challenges of early diagnosis of cancer in primary care - PowerPoint Presentation

conchita-marotz
conchita-marotz . @conchita-marotz
Follow
415 views
Uploaded On 2017-07-09

The challenges of early diagnosis of cancer in primary care - PPT Presentation

Jon Emery Professor of General Practice University of Western Australia Director of PC4 Early cancer diagnosis I went to see my oncologist in hospital earlier this week and we talked about this and that and the importance of catching cancer early which I found a bit annoying as they had ID: 568309

symptom cancer symptoms diagnostic cancer symptom diagnostic symptoms appraisal rural diagnosis early care general survival interval walter practice models

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "The challenges of early diagnosis of can..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

The challenges of early diagnosis of cancer in primary care

Jon EmeryProfessor of General PracticeUniversity of Western AustraliaDirector of PC4Slide2

Early cancer diagnosis

‘I went to see my oncologist in hospital earlier this week and we talked about this and that, and the importance of catching cancer early, which I found a bit annoying as they had not caught my cancer early, but it turned out he was just filling in time and wanted to talk to me about something different.’Slide3

Onctalk.comSlide4

Cochrane review of Hemoccult

screening on colorectal cancer mortalitySlide5

Symptomatic cancer and early diagnosis

Richards et al Lancet 1999Delays from symptoms to diagnosis of 3-6 months associated with 7% worse 5-year survival from breast cancerEffects not due to lead time bias

Longer delays associated with more advanced diseaseSlide6

Colorectal cancer diagnostic interval and mortality

Torring et al BJC 2010Waiting list paradoxDiagnostic intervals >5 weeks associated with worsening mortality if ‘alarm symptoms’.

Similar U-shaped association for lung, melanoma and prostate cancer. Slide7

Variations in cancer survival

International variations in cancer survivalAustralia, Canada and Sweden better than UK and DenmarkDifferences greatest for 1- year survival Slide8

Variations in cancer survival

Rural cancer outcomes in Australia worseApproximately 20% worse 5- year survival for common cancersDifferences in treatments received (eg

radical prostatectomy Baade 2011)Later stage at presentation (eg colorectal cancer Baade 2011)Slide9

Can some of the variations in cancer survival be improved by earlier diagnosis?Slide10

Potential approaches

Improve uptake of proven screening testsSystematic application of evidence around symptoms as predictors of cancerCommunity symptom awarenessGeneral populationTargeted high risk groups

General practice level interventionsTumour markersDiagnostic aidsSlide11

Models of ‘diagnostic delay’

Walter, Scott, Webster, Emery. JHSRP 2011Slide12

Models of ‘diagnostic delay’

First symptom

First contact with the GP

Referral to hospital

Initiation of investigation of cancer-related symptoms

First visit at the hospital

Referral to treatment

Treatment initiation

System delay

Doctor delay

Patient delay

Delay in primary care

Delay in secondary care

F

Olesen

BJC 2009 Slide13

Diagnosing cancer in general practice: how well do symptoms predict cancer?

Shapley et al BJGP 201025 studies includedRectal bleeding; change in bowel habit; iron deficiency anaemia;

haematuria; malignant DRE; haemoptysis; dysphagia; breast lump; post-menopausal bleeding.Slide14

Diagnosing cancer in general practice: how well do symptoms predict cancer?

Hamilton BJC 2005Slide15

Improving Rural Cancer Outcomes Project

Patients with lung, prostate, breast, colorectal cancer in Goldfields and Great Southern

66 patients

Interview patients

Symptom appraisal and help-seeking

Calendar

landmarking

and diagram to aid recall

Medical notes audit

Mixed methods matrix analysis

PerthSlide16

Improving rural cancer outcomes (IRCO) project

Symptom appraisal (days)

GP

interval

(days)

Mean

Median

IQR

[25

th

, 75

th

]

Mean

Median

IQR

[25

th

, 75

th

]

Breast

27

0

0, 13

13

3

1, 40

Colorectal

130

9

0, 49

184

87

48, 139

Lung

36

9

0, 103

61

2

0, 9

Prostate

309

15

12, 28

33

42

10, 263

Significant overall differences between tumour groups for symptom appraisal and GP diagnostic intervals*

* After log transformationSlide17

Symptom appraisal

and patient beliefs

Comparison of symptoms against personal models of disease

Alternative explanations for symptoms

Common misconceptions about cancer symptoms

I mean it’s like you know a horse ,colic in a horse... it comes on pretty damn quick and ... you know you think well, you know I began to think maybe I’ve got a twisted bowel or something.Slide18

Symptom appraisal

and patient beliefs

Comparison of symptoms against personal models of disease

Alternative explanations for symptoms

Common misconceptions about cancer symptoms

And when you’re walking around in slushy mud and all that your gumboots stick to them and you’ve got to ... if you keep doing it long enough your hips get that sore you know?Slide19

Symptom appraisal

and patient beliefs

Comparison of symptoms against personal models of disease

Alternative explanations for symptoms

Common misconceptions about cancer symptoms

The trouble is with cancer, I think you know it creeps in on you and ... and like there’s a bit of blood there but no pain and you think well if there’d been some pain there you’d have definitely said oh shit there’s something wrong here.Slide20

Symptom appraisal & help-seeking in

rural AustraliaThe rural Australian character

And the country men are worse than the women, by a long shot. They’re, you know, bush blokes. You know, “I’m not going to the doctor. I’ll be right, mate.”Slide21

Symptom appraisal & help-seeking in

rural AustraliaFear in relation to rural machismo

Being a real hero bloke, you know, you don’t go to the doctor about that. I’m not going there … going where they

wanna

go,

nup

.Slide22

Symptom appraisal & help-seeking in

rural AustraliaStoic response to symptoms

Well, I had a bit of diarrhoea… And it just didn't want to seem to go away… really I‘d had it for about three months before I went and seen the doctor… I just put up with it … thought oh it'll go away soon…. then I just got sick of it. Yeah, because I had to - I finished up wearing um … [incontinence] pads and things you know.”Slide23

Improving rural cancer outcomes project

Access and Specialist diagnostic interval (days

)

Total diagnostic interval (days)

Mean

Median

IQR

[25

th

, 75

th

]

Mean

Median

IQR

[25

th

, 75

th

]

Breast

22

63

38, 100

80

15

10,29

Colorectal

55

200

125, 421

347

30

16,60

Lung

23

41

22, 203

123

14

11,30

Prostate

99

190

147, 346

357

68

53,83

Overall significant differences between tumour groups in*:

access to specialists

specialist intervals

total diagnostic interval

* After log transformationSlide24

The IRCO Trial

Community level:

Community campaign to reduce symptom appraisal and help-seeking intervalsPractice level: to reduce diagnostic interval

2 x 2 factorial Randomised

Controlled Trial

Outcome: total diagnostic intervalSlide25

Approaches to reducing symptom appraisal and help-seeking intervalsSlide26
Slide27

Improving rural cancer outcomes projectSlide28

Tumour markers in general practice?

In symptomatic diagnosisUseful: α fetoprotein, Bence

Jones protein, HCG, PSAUncertain value: Ca125, Ca-19-9, Of no value: CEA, Ca15-3, thyroglobulinLittle research in primary care populations

Sturgeon et al BMJ 2009Slide29

The BEST Studies

Immunohistochemistry

of trefoil factor 3 (TFF3)

BMJ 2010.

doi:10.1136/bmj.c4372

Sensitivity 90.0%; specificity 93.5% for clinically relevant Barrett’s oesophagus in primary care populationSlide30

Diagnostic aids

Dermoscopy and sequential digital monitoring (Menzies, Emery et al BJD 2009)Doubled sensitivity for diagnosis of melanoma to 97%63.5% reduction in excision of benign lesions

Importance of monitoring strategySlide31

Diagnostic aids

The Molemate TrialSiascopy vs 7-point checklist (Best Practice)

Major features

Minor features

Change in size Largest diameter 7mm+

Irregular shape Inflammation

Irregular colour Oozing

Change in sensationSlide32

The gatekeeper role and early cancer diagnosis

Relative 1-year survival

Median

p-value

Gatekeeper

Yes

67.8

0.004

No

73.4

Primary care 1

st

point of call

Yes

66.3

0.001

No

73.4

Vedsted et al BJGP 2011Slide33

What is the right balance of gatekeeping

for possible cancer?

Emeraldinsight.com

?

? Metro only

?Slide34

Acknowledgements

IRCO teamD’Arcy Holman, Vicky Gray, Emma Croager, Terry Slevin, Christobel Saunders, Fiona Walter and others

Molemate TeamFiona Walter, Helen Morris, Toby Prevost, Ann-Louise Kinmonth, Per Hall and othersDiscovery Team

Willie Hamilton, Fiona Walter, Greg Rubin, Richard Neal and others

Consensus working group on early diagnosis of cancer

David Weller, Greg Rubin, Richard Neal, Fiona Walter, Suzanne Scott, Willie Hamilton,

Frede

Olesen

, Peter Vedsted and others